Jeffrey Tate - 28 Apr 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Issuer symbol
CYTH
Transactions as of
28 Apr 2022
Net transactions value
+$5,279
Form type
4
Filing time
29 Apr 2022, 15:36:26 UTC
Previous filing
02 Mar 2022
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $1,588 +635 +2.3% $2.50 27,795 28 Apr 2022 Direct
transaction CYTH Common Stock Purchase $810 +300 +1.1% $2.70 28,095 29 Apr 2022 Direct
transaction CYTH Common Stock Purchase $2,882 +1,065 +3.8% $2.71 29,160 29 Apr 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.